Microphysiological systems (MPS), consisting of interacting organs-on-chips or tissue-engineered, 3D organ constructs that use human cells, present an opportunity to bring new tools to biology, medicine, pharmacology, physiology, and toxicology. This issue of Experimental Biology and Medicine describes the ongoing development of MPS that can serve as in-vitro models for bone and cartilage, brain, gastrointestinal tract, lung, liver, microvasculature, reproductive tract, skeletal muscle, and skin. Related topics addressed here are the interconnection of organs-on-chips to support physiologically based pharmacokinetics and drug discovery and screening, and the microscale technologies that regulate stem cell differentiation. The initial motivation for creating MPS was to increase the speed, efficiency, and safety of pharmaceutical development and testing, paying particular regard to the fact that neither monolayer monocultures of immortal or primary cell lines nor animal studies can adequately recapitulate the dynamics of drug–organ, drug–drug, and drug–organ–organ interactions in humans. Other applications include studies of the effect of environmental toxins on humans, identification, characterization, and neutralization of chemical and biological weapons, controlled studies of the microbiome and infectious disease that cannot be conducted in humans, controlled differentiation of induced pluripotent stem cells into specific adult cellular phenotypes, and studies of the dynamics of metabolism and signaling within and between human organs. The technical challenges are being addressed by many investigators, and in the process, it seems highly likely that significant progress will be made toward providing more physiologically realistic alternatives to monolayer monocultures or whole animal studies. The effectiveness of this effort will be determined in part by how easy the constructs are to use, how well they function, how accurately they recapitulate and report human pharmacology and toxicology, whether they can be generated in large numbers to enable parallel studies, and if their use can be standardized consistent with the practices of regulatory science.
MartinHN. The direct influence of gradual variations of temperature upon the rate of beat of the dog's heart. Philos Trans R Soc London1883; 174: 663–88.
AvisFR. Investigations of liver and kidney. Design of a dual apparatus for research study. Sci Teacher1961; 28: 14–8.
4.
NeelyJRLiebermeisterHBattersbyEJMorganHE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol1967; 212: 804–14.
5.
NeelyJRLiebermeisterHMorganHE. Effect of pressure development on membrane transport of glucose in isolated rat heart. Am J Physiol1967; 212: 815–22.
6.
ZimmerHG. The isolated perfused heart and its pioneers. News Physiol Sci1998; 13: 203–10.
7.
ExtonJH. Crucible of science: the story of the Cori laboratory, Oxford: Oxford University Press, 2013.
8.
GadamerHG. Truth and method, 2nd ed. New York: Continuum, 2000.
9.
Sorger PK, Allerheiligen SRB, Abernethy DR, Altman RB, Brouwer KLR, Califano A, D'Argenio DZ, Iyengar R, Jusko WJ, Lalonde R, Lauffenburger DA, Shoichet B, Stevens JL, Subramaniam S, Van der Graaf P, Vicini P. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms, http://www.nigms.nih.gov/Training/Documents/SystemsPharmaWPSorger2011.pdf (accessed October 2011).
10.
HuangSWikswoJDimensions of systems biology. In: AmaraSGBambergEGudermannTHebertSCJahnRLedererWJLillRMiyajimaAOffermannsS (eds). Reviews of physiology, biochemistry and pharmacology, 157th ed. Berlin, Heidelberg: Springer, 2007, pp. 81–104.
11.
BissellMJRadiskyD. Putting tumours in context. Nat Rev Cancer2001; 1: 46–54.
12.
BakerBMChenCS. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues. J Cell Sci2012; 125: 3015–24.
13.
KolaILandisJ. Can the pharmaceutical industry reduce attrition rates?Nat Rev Drug Discov2004; 3: 711–5.
14.
AstashkinaAMannBGraingerDW. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther2012; 134: 82–106.
15.
MiesenbockG. Optogenetic control of cells and circuits. Annu Rev Cell Dev Biol2011; 27: 731–58.
16.
ChungKWallaceJKimSYKalyanasundaramSAndalmanASDavidsonTJMirzabekovJJZalocuskyKAMattisJDenisinAKPakSBernsteinHRamakrishnanCGrosenickLGradinaruVDeisserothK. Structural and molecular interrogation of intact biological systems. Nature2013; 497: 332–7.
17.
LeDucPRMessnerWCWikswoJP. How do control-based approaches enter into biology?Annu Rev Biomed Eng2011; 13: 369–96.
18.
WikswoJCurtisELEagletonZEEvansBCKoleAHofmeisterLHMatloffWJ. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip2013; 13: 3496–511.
19.
DomanskyKInmanWSerdyJDashALimMHMGriffithLG. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip2010; 10: 51–8.
20.
HuhDLeslieDCMatthewsBDFraserJPJurekSHamiltonGAThorneloeKSMcAlexanderMAIngberDE. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med2012; 4: 159ra147–159ra147.
21.
KimHJHuhDHamiltonGIngberDE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip2012; 12: 2165–74.
22.
HuhDMatthewsBDMammotoAMontoya-ZavalaMHsinHYIngberDE. Reconstituting organ-level lung functions on a chip. Science2010; 328: 1662–8.
23.
MoraesCLabuzJMLeungBMInoueMChunTHTakayamaS. On being the right size: scaling effects in designing a human-on-a-chip. Integr Biol2013; 5: 1149–61.
24.
ImuraYSatoKYoshimuraE. Micro total bioassay system for ingested substances: assessment of intestinal absorption, hepatic metabolism, and bioactivity. Anal Chem2010; 82: 9983–8.
25.
ShulerMLEschMB. Body-on-a chip: using microfluidic systems to predict human responses to drugs. Pure Appl Chem2010; 82: 1635–45.
26.
EschMBKingTLShulerML. The role of body-on-a-chip devices in drug and toxicity studies. Annu Rev Biomed Eng2011; 13: 55–72.
27.
SungJHEschMBProtJMLongCJSmithAHickmanJJShulerML. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip2013; 13: 1201–12.
28.
WuMHHuangSBLeeGB. Microfluidic cell culture systems for drug research. Lab Chip2010; 10: 939–56.
29.
van der MeerADvan den BergA. Organs-on-chips: breaking the in vitro impasse. Integr Biol2012; 4: 461–70.
30.
MoraesCMehtaGLesher-PerezSCTakayamaS. Organs-on-a-chip: a focus on compartmentalized microdevices. Ann Biomed Eng2012; 40: 1211–27.
Fabre K, Livingston C, Tagle DA. Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue. Exp Biol Med 2014;239:1073–7.
40.
Slikker W Jr. Of human-on-a-chip and humans: considerations for creating and using microphysiological systems. Exp Biol Med 2014;239:1078–9.
41.
Alexander PG, Gottardi R, Lin H, Lozito TP, Tuan RS. Three dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases. Exp Biol Med 2014;239: 1080–95.
42.
Pamies D, Hartung T, Hogberg HT. Biological and medical applications of a brain-on-chip. Exp Biol Med 2014;239:1096–108.
43.
Hartman KG, Bortner JD Jr, Falk GW, Ginsberg GG, Jhala N, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med 2014;239:1108–23.
44.
Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Ettayebi K, Blutt SE, Hyser JM, Zeng X-L, Crawford SE, Broughman JR, Estes MK, Donowitz M. Human enteroids as an ex vivo model of host-pathogen interactions in the GI tract. Exp Biol Med 2014;239:1124–34.
45.
Nichols JE, Niles JA, Vega SP, Argueta LB, Eastaway A, Cortiella J. Modeling the lung: design and development of tissue engineered macro- and micro-physiologic lung models for research use. Exp Biol Med 2014;239:1135–70.
46.
Clark AM, Wheeler SE, Taylor DP, Pillai VC, Young CL, Prantil-Baun R, Nguyen T, Stolz DB, Borenstein JT, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A. A microphysiological system model of therapy for liver micrometastases. Exp Biol Med 2014;239:1170–79.
47.
Bale SS, Vernetti L, Senutovitch N, Jindal R, Hegde M, Gough A, McCarty WJ, Bakan A, Bhushan A, Shun TY, Golberg I, DeBiasio R, Usta BO, Taylor DL, Yarmush ML. In vitro platforms for evaluating liver toxicity. Exp Biol Med 2014;239:1180–92.
48.
Tourovskaia A, Fauver M, Kramer G, Simonson S, Neumann T. Tissue-engineered microenvironment systems for modeling human vasculature. Exp Biol Med 2014;239:1264–71.
49.
Eddie SL, Kim JJ, Woodruff TK, Burdette JE. Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp Biol Med 2014;239:1192–202.
50.
Cheng CS, Davis BNJ, Maddan L, Bursac N, Truskey GA. Physiology and metabolism of tissue engineered skeletal muscle. Exp Biol Med 2014;239:1203–14.
51.
Eungdamrong NJ, Higgins C, Guo Z, Lee W-H, Gillette B, Sia S, Christiano AM. Challenges and promises in modeling dermatologic disorders with bioengineered skin. Exp Biol Med 2014;239:1215–24.
52.
Sung JH, Srinivasan B, Esch MB, McLamb WT, Bernabini C, Shuler ML, Hickman JJ. Using PBPK guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure. Exp Biol Med 2014;239:1125–40.
53.
Heylman C, Sobrino A, Shirure VS, Hughes CCW, George SC. A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. Exp Biol Med 2014;239:1240–54.
54.
Cimetta E, Vunjak-Novakovic G. Microscale technologies for regulating human stem cell differentiation. Exp Biol Med 2014;239:1255–63.
55.
EschMBSungJHShulerML. Promises, challenges and future directions of µCCAs. J Biotechnol2010; 148: 64–9.
56.
WikswoJPBlockFEIIICliffelDEGoodwinCRMarascoCCMarkovDAMcLeanDLMcLeanJAMcKenzieJRReisererRSSamsonPCSchafferDKSealeKTSherrodSD. Engineering challenges for instrumenting and controlling integrated organ-on-a-chip systems. IEEE Trans Biomed Eng2013; 60: 682–90.
57.
YoungEWK. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. Integr Biol2013; 5: 1096–109.
58.
WikswoJPProkopABaudenbacherFCliffelDCsukasBVelkovskyM. Engineering challenges of BioNEMS: the integration of microfluidics, and micro- and nanodevices, models, and external control for systems biology. IEE Proc Nanobiotechnol2006; 153: 81–101.
59.
FaleySSealeKHugheyJSchafferDKVanCompernolleSMcKinneyBBaudenbacherFUnutmazDWikswoJP. Microfluidic platform for real-time signaling analysis of multiple single T cells in parallel. Lab Chip2008; 8: 1700–12.
60.
BoronWFBoulpaepEL. Medical physiology: a cellular and molecular approach, Philadelphia, PA: Elsevier Saunders, 2005.
61.
SungJHShulerML. A micro cell culture analog (µCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip2009; 9: 1385–94.
62.
KimmelDWDoleWPCliffelDE. Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic. Biochem Biophys Res Commun2013; 431: 181–5.
63.
ShinawiTFKimmelDWCliffelDE. Multianalyte microphysiometry reveals changes in cellular bioenergetics upon exposure to fluorescent dyes. Anal Chem2013; 85: 11677–80.
64.
HarryRSHiattLAKimmelDWCarneyCKHalfpennyKCCliffelDEWrightDW. Metabolic impact of 4-Hydroxynonenal on macrophage-like RAW 264.7 function and activation. Chem Res Toxicol2012; 25: 1643–51.
65.
HiattLAMcKenzieJRDeraviLFHarryRSWrightDWCliffelDE. A printed superoxide dismutase coated electrode for the study of macrophage oxidative burst. Biosens Bioelectron2012; 33: 128–33.
66.
KimmelDWLeBlancGMeschievitzMECliffelDE. Electrochemical sensors and biosensors. Anal Chem2012; 84: 685–707.
67.
McKenzieJRPalubinskyAMBrownJEMcLaughlinBCliffelDE. Metabolic multianalyte microphysiometry reveals extracellular acidosis is an essential mediator of neuronal preconditioning. ACS Chem Neurosci2012; 3: 510–8.
68.
SniderRMMcKenzieJRKraftLKozlovEWikswoJPCliffelDE. The effects of cholera toxin on cellular energy metabolism. Toxins2010; 2: 632–48.
69.
ZeigerSLHMcKenzieJRStankowskiJNMartinJACliffelDEMcLaughlinB. Neuron specific metabolic adaptations following multi-day exposures to oxygen glucose deprivation. BBA-Mol Basis Dis2010; 1802: 1095–104.
70.
EklundSEThompsonRGSniderRMCarneyCKWrightDWWikswoJCliffelDE. Metabolic discrimination of select list agents by monitoring cellular responses in a multianalyte microphysiometer. Sensors2009; 9: 2117–33.
71.
EndersJRMarascoCCWikswoJPMcleanJA. A dual-column solid phase extraction strategy for online collection and preparation of continuously flowing effluent streams for mass spectrometry. Anal Chem2012; 84: 8467–74.
72.
ShiMMajumdarDGaoYBrewerBMGoodwinCRMcLeanJALiDWebbDJ. Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. Lab Chip2013; 13: 3008–21.
73.
GubalaVHarrisLFRiccoAJTanMXWilliamsDE. Point of care diagnostics: status and future. Anal Chem2012; 84: 487–515.
74.
SchleicherE. The clinical chemistry laboratory: current status, problems and diagnostic prospects. Anal Bioanal Chem2006; 384: 124–31.
75.
ZaninottoMPlebaniM. The “hospital central laboratory“: automation, integration and clinical usefulness. Clin Chem Lab Med2010; 48: 911–7.
76.
HesterRLIliescuRSummersRColemanTG. Systems biology and integrative physiological modelling. J Physiol Lond2011; 589: 1053–60.
77.
Hester RL, Brown AJ, Husband L, Iliescu R, Pruett D, Summers R, Coleman TG. HumMod: a modeling environment for the simulation of integrative human physiology. Front Physiol 2011;2:Article 12.
78.
FisherRA. The arrangement of field experiments. J Min Agric G Br1926; 33: 503–13.
Basketter DA, Clewell H, Kimber I, Rossi A, Blaauboer B, Burrier R, Daneshian M, Eskes C, Goldberg A, Hasiwa N, Hoffmann S, Jaworska J, Knudsen TB, Landsiedel R, Leist M, Locke P, Maxwell G, Mckim J, Mcvey EA, Ouedraogo G, Patlewicz G, Pelkonen O, Roggen E, Rovida C, Ruhdel I, Schwarz M, Schepky A, Schoeters G, Skinner N, Trentz K, Turner M, Vanparys P, Yager J, Zurlo J, Hartung T. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 2012;29:3–91.
AvisFR. About mice and man. An introduction to advanced biology, Portland, ME: J. Weston Walch, 1962.
86.
RosenbluethAWienerN. The role of models in science. Philos Sci1945; 12: 316–21.
87.
MarkelH. Experiments and observations: how William Beaumont and Alexis St. Martin seized the moment of scientific progress. JAMA2009; 302: 804–6.
88.
MarkelH. Factual error in: experiments and observations: how William Beaumont and Alexis St. Martin seized the moment of scientific progress (vol 302, pg 804, 2009). JAMA2009; 302: 1420–1420.
